A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection
Clinical trial NCT00192647 · COMPLETED
Trial details
- NCT number
- NCT00192647
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2009-03-01
- Enrollment
- 896
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.